TY  - JOUR
AU  - Fobelo Lozano, María José
AU  - Serrano Giménez, Reyes
AU  - Sánchez Fidalgo, Susana
PY  - 2019
DO  - 10.1111/bcp.14062
UR  - http://hdl.handle.net/10668/14249
T2  - British journal of clinical pharmacology
AB  - Available evidence indicates that a therapeutic drug monitoring strategy leads to major cost savings related to the anti-tumour necrosis factor-α therapy in both inflammatory bowel disease and rheumatoid arthritis (RA) patients, with no negative...
LA  - en
KW  - ankylosing spondylitis
KW  - infliximab
KW  - pharmacokinetics
KW  - spondyloarthritis
KW  - therapeutic drug monitoring
KW  - Antirheumatic Agents
KW  - Drug Monitoring
KW  - Humans
KW  - Infliximab
KW  - Spondylarthritis
KW  - Tumor Necrosis Factor-alpha
TI  - Therapeutic drug monitoring of infliximab in spondyloarthritis. A review of the literature.
TY  - research article
VL  - 85
ER  -